Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | QDPR | P09417 | 3/20 | 0.32 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23250752 | 0.72 | HDAC4 (0.53) | HDAC4HDAC2HDAC8QDPRACMSD | |
| SCHEMBL27304361 | 0.71 | HDAC4 (0.41) | HDAC4HDAC2HDAC8QDPRESR2 | |
| SCHEMBL27304483 | 0.70 | HDAC4 (0.39) | HDAC4HDAC2HDAC8QDPR | |
| SCHEMBL23250714 | 0.69 | HDAC4 (0.45) | HDAC4HDAC2HDAC8QDPRESR2 | |
| SCHEMBL23258718 | 0.69 | HDAC4 (0.45) | HDAC4HDAC2HDAC8QDPRESR2 | |
| SCHEMBL21471548 | 0.69 | HDAC4 (0.74) | HDAC4HDAC2HDAC8QDPRACMSD | |
| SCHEMBL21471547 | 0.68 | HDAC4 (0.72) | HDAC4HDAC2HDAC8QDPRACMSD | |
| SCHEMBL23258566 | 0.65 | QDPR (0.62) | HDAC4HDAC2HDAC8QDPR | |
| SCHEMBL23258680 | 0.65 | HDAC4 (0.54) | HDAC4HDAC2HDAC8QDPRACMSD | |
| SCHEMBL27304482 | 0.65 | HDAC4 (0.44) | HDAC4HDAC2HDAC8QDPRACMSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024073131-A2 | METHOD OF TREATING NEURODEGENERATIVE DISEASES | THE BOARD OF TRUSTEES OF THE UNIVESITY OF ILLINOIS (US) | 2024-04-04 | — | — | WO | disclosed |